SCHEMBL7209100

SCHEMBL7209100

COC(=O)Nc1ccccc1CBr

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.46
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587541 0.85 ALDH1A1 (0.54) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL1836106 0.85 L3MBTL1 (0.51) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL27693435 0.85 SMN1; SMN2 (0.49) HPGDALDH1A1ALOX15L3MBTL1KMT2A
SCHEMBL29960499 0.84 HPGD (0.56) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL2462870 0.84 HPGD (0.56) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL5871517 0.83 LMNA (0.48) ALDH1A1LMNAL3MBTL1POLB
SCHEMBL22323901 0.83 L3MBTL1 (0.46) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL2463257 0.82 HPGD (0.46) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL8173356 0.82 ALDH1A1 (0.46) HPGDALDH1A1LMNAALOX15HSD17B10
SCHEMBL7236261 0.81 ALDH1A1 (0.55) HPGDALDH1A1LMNAHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
CN-106083722-A A kind of Six Steps prepares the synthesis technique of pyrazoles Fluoxastrobin 安徽广信农化股份有限公司 2016-11-09 CN disclosed
US-20120148521-A1 Methods and Compositions for Controlled Release of Drugs THE UNIVERSITY OF WYOMING 2012-06-14 US disclosed
US-8105570-B2 Covalently bond to polymer or other moiety that blocks activity until reaching delivery site; not easily circumventable THE UNIVERSITY OF WYOMING (US) 2012-01-31 US disclosed
EP-0987255-B1 Substituted aminoquinazolinone (thione) derivatives NIHON NOHYAKU CO LTD (JP) 2003-07-16 EP disclosed
EP-0735035-B1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same NIHON NOHYAKU CO LTD (JP) 2002-06-05 EP disclosed
US-6075148-A CARBAMATE DERIVATIVES ARE USEFUL FOR CONTROLLING FUNGI, INSECTS, NEMATODES AND SPIDER MITES BASF AKTIENGESELLSCHAFT (DE) 2000-06-13 US disclosed
EP-0987255-A2 Substituted aminoquinazolinone (thione) derivatives NIHON NOHYAKU CO., LTD. (JP) 2000-03-22 EP disclosed
US-5981532-A FOR CONTROLLING FUNGI, INSECTS, NEMATODES AND SPIDER MITES BASF AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed
US-5824705-A FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-10-20 US disclosed
US-5714492-A INSECTICIDES NIHON NOHYAKU CO., LTD. (JP) 1998-02-03 US disclosed
EP-0735035-A1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same NIHON NOHYAKU CO., LTD. (JP) 1996-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 HPGD 4800/4885ALDH1A1 1238/4885LMNA 2808/4885
US-20120148521-A1 Methods and Compositions for Controlled Release of Drugs OPRK1, OPRM1, AANAT HPGD 889/4885ALDH1A1 342/4885LMNA 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.